Neuronal splicing regulator RBFOX3 mediates seizures via regulating Vamp1 expression preferentially in NPY-expressing GABAergic neurons

Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2203632119. doi: 10.1073/pnas.2203632119. Epub 2022 Aug 11.

Abstract

Epilepsy is a common neurological disorder, which has been linked to mutations or deletions of RNA binding protein, fox-1 homolog (Caenorhabditis elegans) 3 (RBFOX3)/NeuN, a neuronal splicing regulator. However, the mechanism of seizure mediation by RBFOX3 remains unknown. Here, we show that mice with deletion of Rbfox3 in gamma-aminobutyric acid (GABA) ergic neurons exhibit spontaneous seizures and high premature mortality due to increased presynaptic release, postsynaptic potential, neuronal excitability, and synaptic transmission in hippocampal dentate gyrus granule cells (DGGCs). Attenuating early excitatory gamma-aminobutyric acid (GABA) action by administering bumetanide, an inhibitor of early GABA depolarization, rescued premature mortality. Rbfox3 deletion reduced hippocampal expression of vesicle-associated membrane protein 1 (VAMP1), a GABAergic neuron-specific presynaptic protein. Postnatal restoration of VAMP1 rescued premature mortality and neuronal excitability in DGGCs. Furthermore, Rbfox3 deletion in GABAergic neurons showed fewer neuropeptide Y (NPY)-expressing GABAergic neurons. In addition, deletion of Rbfox3 in NPY-expressing GABAergic neurons lowered intrinsic excitability and increased seizure susceptibility. Our results establish RBFOX3 as a critical regulator and possible treatment path for epilepsy.

Keywords: GABAergic neurons; NPY; RBFOX3; Seizure; VAMP1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bumetanide / pharmacology
  • DNA-Binding Proteins* / genetics
  • DNA-Binding Proteins* / metabolism
  • Dentate Gyrus / metabolism
  • GABA Antagonists / pharmacology
  • GABAergic Neurons* / metabolism
  • Gene Deletion
  • Mice
  • Nerve Tissue Proteins* / genetics
  • Nerve Tissue Proteins* / metabolism
  • Neuropeptide Y* / metabolism
  • Seizures* / genetics
  • Seizures* / metabolism
  • Vesicle-Associated Membrane Protein 1* / genetics
  • Vesicle-Associated Membrane Protein 1* / metabolism
  • gamma-Aminobutyric Acid / metabolism

Substances

  • DNA-Binding Proteins
  • GABA Antagonists
  • Nerve Tissue Proteins
  • NeuN protein, mouse
  • Neuropeptide Y
  • Vesicle-Associated Membrane Protein 1
  • vesicle-associated membrane protein 1, mouse
  • Bumetanide
  • gamma-Aminobutyric Acid